Introduction

Members from across the DMPK research community are encouraged to join colleagues from across academic, industrial, and third-sector institutions and contribute to the ongoing discussion, evolution and application of DMPK in various scenarios.

The event programme will incorporate sessions themed around the following key topics:
- DMPK and Drug Discovery
- Analytical and Computational Advances in DMPK

In addition, the programme also includes a keynote talk, ‘flash’ presentations from early career researchers, and opportunities for open debate and discussion.

Who should attend?
Medicinal chemists, drug discovery scientists, pharmacologists, toxicologists, DMPK scientists – from academia, industry, and third sector institutions.

Confirmed Speakers
Please see our website for regular updates on confirmed speaker details.

Call for Abstracts
The call for abstracts is open, and abstracts are invited for both oral & poster presentation. The closing dates are 25th November (oral) and 13th January (poster). At the time of submission, poster presenters are asked whether they wish also to be considered for a short oral presentation.

Registration, Students, and Bursaries
Registration will open shortly, and discounted rates will be offered to members of the RSC and the DMDG. Those registering before the early-bird deadline will be eligible for further reduced registration rates. A number of student/early career researcher bursaries will also be available.
An optional conference dinner is available at additional cost – see registration website for more information.

Sponsorship and Exhibition Opportunities
Sponsorship and exhibition opportunities are available for this meeting. Please contact the secretariat for further details. Exhibition stand spaces include one full delegate, and there is the opportunity to sponsor delegate pack inserts and conference social events.

Organising Committee
Toby Athersuch, Imperial College London and the DMG
Dean Naisbitt, University of Liverpool
Xiaoli Meng, University of Liverpool
Mark Seymour, PharMAS Consulting and DMDG
Andrew Stachulski, University of Liverpool and RSC-BMCS